7. The Health Theme: Structure Activity 1: Biotechnology, generic tools & technologies for health Activity 2: Translating research for human health Activity 3: Optimising the delivery of health care cross-cutting issues: international cooperation, SMEs, child health, ageing populations, gender -related health issues Activity 4: Support actions & response to policy needs The Innovative Medicines Initiative
8. Health Theme Funding 2007 - 2013 Year Total Funding Projects Funded 2007 € 641 million 153 2008 € 577 million 172 2009 € 611 million 105 2010 € 621 million 131 2011 € 650 million ~126 2012 € 620 million ? 2013 € 780 million ?
10. UK FP7 Health Theme in Numbers* Submissions with UK partners = 3264* Successful projects with UK partners = 859 UK coordinated submissions = 383 93 projects coordinated by UK partners *2007 – 2009 data – from GAs and participants database (released on 1 May 2010 - data cut-off date 25 March 2010 52 UK SMEs in active FP7 projects (plus 17 new 2010)
15. WP First Draft Open day (Brussels) 09 June 2011 Call published Stage 1 Deadline NCP Roadshow Evaluation results Evaluation PC Meetings Collaborative Research: When?
16. Framework Programme 7 Support and Further Information Graham Hughes, FP7UK NCP for Health (Industry)
22. Framework Programme 7 2012 Call Information Graham Hughes, FP7UK NCP for Health (Industry)
23.
24.
25.
26.
27.
28. Health Theme Funding 2007 - 2013 Year Total Funding Projects Funded SME Targeted 2 Stage 2007 € 641 million 153 0% 0 2008 € 577 million 172 0% 0 2009 € 611 million 105 0% 0 2010 € 621 million 131 0% 19% 2011 € 650 million ~126 20% 75% 2012 € 620 million ? 53% 100% 2013 € 780 million ? ~ 50% 100%
29.
30.
31.
32.
33.
34. 1.4: Innovative Therapeutic Approaches and Interventions >15% >15% EIP > 50% > 30% Tech Tech * 1.4-3 requires cooperation with Australia Clin Transplantation topics have not featured highly in FP7 to date 1.4-1 Innovative approaches to solid organ transplantation 6,000,000 >1 1.4-2 Medical technology for the transplantation sector and bioartificial organs 6,000,000 >1 1.4-3* Innovative strategies for translation of stem cell based therapies in regenerative medicine 6,000,000 1 1.4-4 Targeted nucleic acid delivery as an innovative therapeutic or prophylactic approach 6,000,000 >1
35.
36.
37.
38.
39.
40. 2.4.3: Diabetes and Obesity Clin > 30% Tech 2.4.3-1 Innovative approach to manage diabetes 6,000,000 >1 2.4.3-2 Investigator-driven clinical trials for type 1 diabetes research 6,000,000 >1
41. 2.4.4: Rare Diseases Clin Clin > 30% 2.4.4-1 Preclinical and/or clinical development of substances with a clear potential as orphan drugs 6,000,000 >1 2.4.4-2 Observational trials in rare diseases 3,000,000 >1 2.4.4-3 Best practice and knowledge sharing in the clinical management of rare diseases 2,000,000 1
42. 2.4.5: Other Chronic Diseases EIP > 50% >15% EIP Tech Tech 2.4.5-1 Technological approaches to to combating sensory impairments 6,000,000 >1 2.4.5-2 Biomarkers and diagnostics for chronic inflammatory diseases of the joints 6,000,000 >1
43.
44.
45.
46. Other Health Related EU Funding Sources 2011 Nanosciences, Materials and Production NMP NMP.2012.1.2-2: Development and phase-I clinical trials of novel therapeutic nanotechnology-enabled systems for the diagnosis and treatment of atherosclerosis NMP.2012.2.2-1: Biomaterials for improved performance of medical implants Likely timeframe similar to Health call
47.
Hinweis der Redaktion
Introduce myself work for Beta Technology contracted to TSB to provide the NCP service for the UK (Health) NCP role support for institutions wanting to access EU funding through the framework programme. publicity, advice, support, facilitation Ascertain how many have heard of Framework program
So how is the Framework Program structured? First of all it is broken down into the major themes. Cooperation : the one we are most interested in and the core of FP7. It is designed to foster collaborative research across Europe and other partner countries through funded projects performed by transnational consortia of industry and academia Ideas: this theme supports frontier research solely on the basis of scientific excellence. Covers any area of science and technology, including socio-economic sciences and humanities. No obligation for cross-border partnerships – projects performed around individual teams. Implemented under the new European Research Council People : provides support for researcher mobility and career development both within the EU and internationally. Can provide initial training, industry-academia partnerships, funding of regional, national and international mobility programs. Capacities : designed to strengthen the research capacities that Europe needs to become a knowledge based economy. Programmes support research infrastructure with specific funding of projects by SMEs across a wide range of disciplines. Nuclear Research : lumps together all nuclear research including fusion energy, radiation protection, nuclear waste, support for EU policy making
Let’s now focus on the Cooperation Theme, which attracts 60% of all Framework funding. It is broken down into ten different Program areas, each of which is allocated its own budget. Can see that the two biggest tranches of money are given to ICT and Health. Research activities in all these Program areas are driven by yearly “top down” calls for projects which describe specific topics and research areas. Projects are invited from trans-national consortia that meet the scope of the individual topic areas. There are, unfortunately a complex set of rules that these projects must follow, based around the project type, the construction of the consortium and the specific funding scheme that is determined for each subject. Not going to go into that detail now. A portion of the budget allocation for each programme is allocated with each call, for example this year the Health call was worth €651 million
So what are the benefits of participation? There are a number, as shown here. Access to new networks and contacts – once in a consiortium can leverage the additional networks from other partners Money, obviously. Funding of a project could release resources for other activities. Profile ; increased visibility across the European stage could lead to further opportunities.
So what are the benefits of participation? There are a number, as shown here. Access to new networks and contacts – once in a consiortium can leverage the additional networks from other partners Money, obviously. Funding of a project could release resources for other activities. Profile ; increased visibility across the European stage could lead to further opportunities.
Again, the aim is to promote co-operation both trans-nationally within Europe and internationally so the programmes are usually open to a wide range of countries: EU Member States – have broadest rights and access Associated Countries, those with close associations with EC or seeking membership ICPCs – specific countries or groups of countries that receive preference for specific call topics Industrialised high income countries can participate but generally these will be expected to finance themselves The funding structure of the individual calls will specify specific conditions depending upon the nature of the topic but the basic rule is that there should be a minimum of three different legal entities from three different member states making up the core of the consortium.
Again, the aim is to promote co-operation both trans-nationally within Europe and internationally so the programmes are usually open to a wide range of countries: EU Member States – have broadest rights and access Associated Countries, those with close associations with EC or seeking membership ICPCs – specific countries or groups of countries that receive preference for specific call topics Industrialised high income countries can participate but generally these will be expected to finance themselves The funding structure of the individual calls will specify specific conditions depending upon the nature of the topic but the basic rule is that there should be a minimum of three different legal entities from three different member states making up the core of the consortium.
Introduce myself work for Beta Technology contracted to TSB to provide the NCP service for the UK (Health) NCP role support for institutions wanting to access EU funding through the framework programme. publicity, advice, support, facilitation Ascertain how many have heard of Framework program
Introduce myself work for Beta Technology contracted to TSB to provide the NCP service for the UK (Health) NCP role support for institutions wanting to access EU funding through the framework programme. publicity, advice, support, facilitation Ascertain how many have heard of Framework program
Always informative to see what factors are driving the direction of the WP Part of the Europe 2020 growth strategy with 5 key targets 75% of 20 – 64 age group in employment 3% GDP spent on R&D Greenhouse gas emissions 20% lower than 1990 School drop out rates < 10% 20 million fewer people in poverty The Innovation Union aims to improve conditions and access to finance for research and innovation in Europe, to ensure that innovative ideas can be turned into products and services that create growth and jobs.
Starred topic areas have been closed for two successive calls
Going to cover call topics by sub theme and call priority. Some will fall into two or even three categories so may repeat Don’t have time to go through each one in detail. If you identify any that you are interested in make a note then contact me or Vic to get details or discuss in detail.